Large Urology Group Practice Association
Client is a membership association for large physician group practices.
Based in IL
🤖
AI Overview
With $2.7M in lobbying spend across 30 quarterly filings, Large Urology Group Practice Association is a significant lobbying presence.
$2.7M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
7
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $360K |
| 2019 | $450K |
| 2020 | $270K |
| 2021 | $180K |
| 2022 | $360K |
| 2023 | $360K |
| 2024 | $360K |
| 2025 | $360K |
Lobbying Firms
THE MCMANUS GROUP
What They Lobby For
- Support for H.R. 539 - USPSTF Transparency and Accountability Act of 2017.
- Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017
- Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017.
- Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, 83 Fed. Reg. 37046.
- Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546).
- Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
- Support for reforming the United States Preventive Services Task Force.
- Support H.R. 3534, the USPSTF Transparency Accountability Act of 2019.
- Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
- Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.